The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Anti‐MuSK patient antibodies disrupt the mouse neuromuscular junction
Abstract
Objective: A subset of myasthenia gravis patients that are seronegative for anti‐acetylcholine receptor (anti‐AChR) antibodies are instead seropositive for antibodies against the muscle‐specific kinase (anti‐MuSK–positive). Here, we test whether transfer of IgG from anti‐MuSK–positive patients to mice confers impairment of the neuromuscular junction and muscle weakness. Methods: IgG from anti‐MuSK–positive myasthenia gravis patients or control IgG (seronegative for AChR and MuSK) was injected intraperitoneally (45mg daily for 14 days) into 6‐week‐old female FVB/NJ and C57BL/6J mice. Changes at neuromuscular junctions in the tibialis anterior and diaphragm muscles were assessed by confocal fluorescent imaging of AChRs stained with fluorescent‐α‐bungarotoxin. Loss of function was assessed by electromyography. Results: In experimental mice injected with anti‐MuSK–positive patient IgG, postsynaptic AChR staining was reduced to as little as 22% of that seen in control mice. Experimental mice showed reduced apposition of the nerve terminal (labeled with antibodies against synaptophysin and neurofilament) and the postsynaptic AChR cluster (labeled with fluorescent‐α‐bungarotoxin). Mice injected with IgG from two of three anti‐MuSK–positive patients lost weight and developed muscle weakness associated with a decremental electromyographic trace on repetitive nerve stimulation. Interpretation: IgG from anti‐MuSK–positive patients can cause myasthenia gravis when injected into mice. This may be explained by a progressive reduction in the density of postsynaptic AChR combined with changes in the nerve terminal and its relation to the postsynaptic structure. Ann Neurol 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MUSK, a new target for mutations causing congenital myasthenic syndrome
Chevessier, F., Faraut, B., Ravel-Chapuis, A., Richard, P., Gaudon, K., Bauché, S., Prioleau, C., Herbst, R., Goillot, E., Ioos, C., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh333 · Cited by 193
Cited by
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Meriggioli, M. N., & Sanders, D. B. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70063-8 · Cited by 894
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
Dresser, L., Wlodarski, R., Rezania, K., & Soliven, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112235 · Cited by 475
Tzartos, J. S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2393 · Cited by 342
Melzer, N., Ruck, T., Fuhr, P., Gold, R., Hohlfeld, R., Marx, A., Melms, A., Tackenberg, B., Schalke, B., Schneider-Gold, C., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8045-z · Cited by 292
Metadata
- Authors
- Cole, R. N., Reddel, S. W., Gervásio, O. L., & Phillips, W. D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-04-02
- Volume
- 63
- Issue
- 6
- Pages
- 782-789
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2007294766
- Cited by
- 174
- References
- 1
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐MuSK patient antibodies disrupt the mouse neuromuscular junction. https://app.cochat.ai/papers/10.1002/ana.21371
- The paper
- Cole, R. N., Reddel, S. W., Gervásio, O. L., & Phillips, W. D. (2008). Anti‐MuSK patient antibodies disrupt the mouse neuromuscular junction. Annals of Neurology. https://doi.org/10.1002/ana.21371
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.